HLA-DR3 ~ DQ2 associates with sensory neuropathy in paraneoplastic neurological syndromes with Hu antibodies. [PDF]
Muñiz-Castrillo S +8 more
europepmc +1 more source
Paraneoplastic Neurological Syndromes as Initial Presentation of Tumors: An Eight-Year Single-Center Experience. [PDF]
Melanis K +14 more
europepmc +1 more source
Significant improvement in paraneoplastic neurological syndromes without identifiable anti-neural antibodies in patients with breast cancer after breast surgery. [PDF]
Oshino T +9 more
europepmc +1 more source
Antibodies to TRIM46 are associated with paraneoplastic neurological syndromes. [PDF]
van Coevorden-Hameete MH +12 more
europepmc +1 more source
Various clinical features of patients with anti-Hu associated paraneoplastic neurological syndromes: An observational study. [PDF]
Li J, Lin W.
europepmc +1 more source
Lung Cancer Wherein Durvalumab Induced Both Anti-CRMP-5 Antibody-related Paraneoplastic Neurological Syndromes and Neurological Adverse Events. [PDF]
Seki T +10 more
europepmc +1 more source
Early intravenous immunoglobulin treatment in paraneoplastic neurological syndromes with onconeural antibodies. [PDF]
Berzero G +14 more
europepmc +1 more source
Paraneoplastic Syndromes in Neurology
Paraneoplastic neurological syndromes (PNS) are a broad group of disorders affecting central and peripheral nervous system which result from an unregulated immune response to the nervous system mediated by different types of neoplasms. The clinical features of PNS frequently appear prior a diagnosis of a neoplasm, therefore recognition of these ...
openaire +1 more source
Paraneoplastic Neurological Syndromes and Glutamic Acid Decarboxylase Antibodies. [PDF]
Ariño H +12 more
europepmc +1 more source

